KLRA Kailera Therapeutics, Inc. - Common stock
$18,21
Harga · Agu 19, 2026
Fundamental per Agu 12, 2026
Rentang 52M
$16–$28
15% of range
Peringkat Analis
BUY
12 analysts
Target Harga
$42
+133% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
KLRA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$18.21
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$16 – $28
KLRA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
KLRA
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
KLRA
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
KLRA
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
KLRA
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
KLRA
Median Rekan
KLRA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
12 analis
- Beli Kuat 5 41,7%
- Beli 6 50,0%
- Tahan 1 8,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
5 analis · 2026-08-18
Median
$41.00
← Di bawah semua target
$18.21
Rendah
$30.00
Tinggi
$57.00
Target median
$41.00
+125,2%
Target rata-rata
$42.40
+132,8%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.14%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-1.09 | $-0.77 | -0.33% |
| 31 Maret 2026 | $-0.64 | $-0.69 | 0.05% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| KLRA | — | — | — | — | — | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| COAG | — | — | — | — | — | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| GENB | — | — | — | — | — | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca 20
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $160M | |
| Short-term Investments | $386M | |
| Prepaid Expense | $11M | |
| Other Current Assets | $2M | |
| Current Assets | $558M | |
| PP&E (Net) | $2M | |
| Other Non-current Assets | $3M | |
| Total Assets | $692M | |
| Accounts Payable | $8M | |
| Accrued Liabilities | $38M | |
| Current Liabilities | $46M | |
| Capital Leases | $10M | |
| Other Non-current Liabilities | $270.0K | |
| Total Liabilities | $56M | |
| Common Stock | $0 | |
| Retained Earnings | $-369M | |
| AOCI | $229.0K | |
| Stockholders' Equity | $-356M | |
| Liabilities + Equity | $692M | |
| Shares Outstanding | 19,048 |
Laporan Laba Rugi 11
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| R&D Expense | $101M | $71M | |
| SG&A Expense | $20M | $14M | |
| Operating Expenses | $121M | $85M | |
| Operating Income | $-121M | $-85M | |
| Other Non-op | $72.0K | $6M | |
| Net Income | $-111M | $-79M | |
| EPS (Basic) | $-1.09 | $-3650.00 | |
| EPS (Diluted) | $-1.09 | $-3650.00 | |
| Shares (Basic) | 102,226,608 | 21,607 | |
| Shares (Diluted) | 102,226,608 | 21,607 | |
| EBITDA | $-121M | $-85M |
Neraca 20
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $130M | $112M | |
| Short-term Investments | $786M | $407M | |
| Prepaid Expense | $12M | $11M | |
| Other Current Assets | $395.0K | $360.0K | |
| Current Assets | $929M | $530M | |
| PP&E (Net) | $2M | $2M | |
| Other Non-current Assets | $90.0K | $6M | |
| Total Assets | $1.21B | $625M | |
| Accounts Payable | $19M | $7M | |
| Accrued Liabilities | $63M | $47M | |
| Current Liabilities | $84M | $55M | |
| Capital Leases | $9M | $9M | |
| Other Non-current Liabilities | $135.0K | $201.0K | |
| Total Liabilities | $93M | $64M | |
| Common Stock | $0 | $0 | |
| Retained Earnings | $-559M | $-448M | |
| AOCI | $-2M | $-532.0K | |
| Stockholders' Equity | $1.12B | $-432M | |
| Liabilities + Equity | $1.21B | $625M | |
| Shares Outstanding | 129,620,370 | 29,953 |
Arus Kas 6
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| D&A | $101.0K | $101.0K | |
| Stock-based Comp | $8M | $4M | |
| Other Non-cash | · | $7M | |
| Operating Cash Flow | $-78M | $-68M | |
| Investing Cash Flow | $-571M | $23M | |
| Financing Cash Flow | $667M | $-3M |
Profitabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| ROA | -18.4% | -25.2% | |
| ROE | -19.9% | 36.5% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 11.1 | 9.7 | |
| Quick Ratio | 11.0 | 9.5 |
Valuasi (TTM) 3
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Market Cap | $2.86B | · | |
| P/B | 2.6 | · | |
| P / Tangible Book | 2.6 | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Orang dalam perusahaan 15 orang dalam · 8 pejabat · 7 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Ronald C Renaud JR | CEO & President | 9 Juni 2026 M | 38.094 | 0 | 0 | $0 |
| Douglas W. Pagan | Chief Financial Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Paul D. Burgess | Chief Operating Officer & Chief Business Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | Chief Corporate Affairs Officer | 6 Juli 2026 A | — | 0 | 0 | $0 |
| Scott M. Wasserman | Chief Medical Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Jamie Beth Coleman | Chief Commercial Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Scott Akamine | Chief Legal Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Paula Cloghessy | Chief People Officer | 16 April 2026 A | — | 0 | 0 | $0 |
| Christopher Hite | Direktur | 16 April 2026 A | — | 0 | 0 | $0 |
| Frank Clyburn | Direktur | 16 April 2026 A | — | 0 | 0 | $0 |
| Andrew T. Kaplan | Direktur | 16 April 2026 A | 26.255.581 | 1 | 0 | $134.375.008 |
| Adam Koppel | Direktur | 16 April 2026 A | 22.583.268 | 1 | 0 | $25.000.000 |
| Martin Mackay | Direktur | 16 April 2026 A | — | 0 | 0 | $0 |
| John F Milligan | Direktur | 16 April 2026 A | — | 0 | 0 | $0 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Pemilik 10% | 20 April 2026 C | 2.034.133 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| BCLS Fund IV Investments, L.P. | 23 April 2026 | 17,43% | Pengajuan awal | Investasi pasif | SEC |
| BCPE Perseus Investor, LP | 23 April 2026 | 20,27% | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 15 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| ITOT · iShares Trust | — | — | 22 Juli 2026 | Harian |
| IWV · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWN · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IWO · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 Juli 2026 | Harian |
| ISCB · iShares Trust | — | — | 20 Juli 2026 | Harian |